Iguana Healthcare Management as of Sept. 30, 2017
Portfolio Holdings for Iguana Healthcare Management
Iguana Healthcare Management holds 68 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 6.0 | $11M | 75k | 145.83 | |
| Esperion Therapeutics (ESPR) | 4.1 | $7.5M | 150k | 50.12 | |
| Immunomedics | 3.8 | $7.0M | 500k | 13.98 | |
| Clovis Oncology | 3.6 | $6.6M | 80k | 82.40 | |
| Biogen Idec (BIIB) | 3.4 | $6.3M | 20k | 313.10 | |
| Clovis Oncology | 3.4 | $6.2M | 75k | 82.40 | |
| Abbvie (ABBV) | 3.1 | $5.8M | 65k | 88.86 | |
| Alexion Pharmaceuticals | 3.1 | $5.6M | 40k | 140.30 | |
| CIGNA Corporation | 2.7 | $5.0M | 27k | 186.94 | |
| Aerie Pharmaceuticals | 2.6 | $4.9M | 100k | 48.60 | |
| Merck & Co (MRK) | 2.6 | $4.8M | 75k | 64.03 | |
| Abbott Laboratories (ABT) | 2.5 | $4.5M | 85k | 53.36 | |
| Aetna | 2.5 | $4.5M | 29k | 159.02 | |
| Karyopharm Therapeutics (KPTI) | 2.4 | $4.4M | 400k | 10.98 | |
| K2m Group Holdings | 2.3 | $4.2M | 200k | 21.21 | |
| Global Blood Therapeutics In | 2.1 | $3.9M | 125k | 31.05 | |
| Medicines Company | 2.0 | $3.7M | 100k | 37.04 | |
| Boston Scientific Corporation (BSX) | 2.0 | $3.6M | 125k | 29.17 | |
| Bristol Myers Squibb (BMY) | 1.9 | $3.5M | 55k | 63.75 | |
| Zimmer Holdings (ZBH) | 1.9 | $3.5M | 30k | 117.10 | |
| Eli Lilly & Co. (LLY) | 1.9 | $3.4M | 40k | 85.55 | |
| Dermira | 1.8 | $3.4M | 125k | 27.00 | |
| Juno Therapeutics | 1.8 | $3.4M | 75k | 44.87 | |
| Glaukos (GKOS) | 1.8 | $3.3M | 100k | 33.00 | |
| Tesaro | 1.8 | $3.2M | 25k | 129.12 | |
| Danaher Corporation (DHR) | 1.6 | $3.0M | 35k | 85.77 | |
| Sangamo Biosciences (SGMO) | 1.6 | $3.0M | 200k | 15.00 | |
| Intersect Ent | 1.5 | $2.8M | 90k | 31.16 | |
| Merus N V (MRUS) | 1.5 | $2.8M | 140k | 19.87 | |
| Ultragenyx Pharmaceutical (RARE) | 1.4 | $2.7M | 50k | 53.26 | |
| Acceleron Pharma | 1.4 | $2.6M | 70k | 37.31 | |
| Pfizer (PFE) | 1.2 | $2.1M | 60k | 35.70 | |
| Fibrogen (FGEN) | 1.2 | $2.2M | 40k | 53.80 | |
| Chemocentryx | 1.1 | $2.0M | 275k | 7.42 | |
| Cymabay Therapeutics | 1.1 | $2.0M | 250k | 8.06 | |
| Cardinal Health (CAH) | 1.1 | $2.0M | 30k | 66.93 | |
| Adma Biologics (ADMA) | 0.9 | $1.7M | 565k | 3.08 | |
| Anaptysbio Inc Common (ANAB) | 0.9 | $1.7M | 50k | 34.96 | |
| Avexis | 0.9 | $1.7M | 18k | 96.74 | |
| Express Scripts Holding | 0.9 | $1.6M | 25k | 63.32 | |
| Oncomed Pharmaceuticals | 0.9 | $1.6M | 350k | 4.52 | |
| Insmed (INSM) | 0.8 | $1.6M | 50k | 31.22 | |
| Ignyta | 0.8 | $1.5M | 125k | 12.35 | |
| Arena Pharmaceuticals | 0.8 | $1.5M | 60k | 25.50 | |
| Corium Intl | 0.8 | $1.4M | 125k | 11.08 | |
| Kura Oncology (KURA) | 0.7 | $1.3M | 90k | 14.96 | |
| Cytomx Therapeutics (CTMX) | 0.7 | $1.3M | 70k | 18.17 | |
| Diplomat Pharmacy | 0.7 | $1.2M | 60k | 20.72 | |
| Catalent (CTLT) | 0.7 | $1.2M | 30k | 39.93 | |
| Wave Life Sciences (WVE) | 0.7 | $1.2M | 55k | 21.75 | |
| Teladoc (TDOC) | 0.6 | $1.2M | 35k | 33.14 | |
| Ascendis Pharma A S (ASND) | 0.6 | $1.1M | 30k | 36.27 | |
| Marinus Pharmaceuticals | 0.6 | $1.0M | 175k | 5.87 | |
| Sierra Oncology | 0.5 | $930k | 600k | 1.55 | |
| Amicus Therapeutics (FOLD) | 0.5 | $905k | 60k | 15.08 | |
| Incyte Corp option | 0.5 | $876k | 7.5k | 116.80 | |
| Paratek Pharmaceuticals | 0.5 | $879k | 35k | 25.11 | |
| Ionis Pharmaceuticals (IONS) | 0.4 | $761k | 15k | 50.73 | |
| Zogenix | 0.4 | $701k | 20k | 35.05 | |
| Exelixis Inc Cmn Stk cmn | 0.3 | $606k | 25k | 24.24 | |
| Neovasc | 0.3 | $612k | 360k | 1.70 | |
| Scynexis | 0.3 | $603k | 250k | 2.41 | |
| Voyager Therapeutics (VYGR) | 0.3 | $515k | 25k | 20.60 | |
| Ptc Therapeutics | 0.3 | $500k | 25k | 20.00 | |
| Achaogen | 0.3 | $479k | 30k | 15.97 | |
| Obseva Sa | 0.2 | $407k | 50k | 8.14 | |
| Ignyta Inc call | 0.2 | $309k | 25k | 12.36 | |
| Adaptimmune Therapeutics (ADAP) | 0.1 | $205k | 25k | 8.20 |
